Serevent

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Salmeterol xinafoate 36.3ug equivalent to to 25 µg Salmeterol base per acuation;  

Available from:

GlaxoSmithKline NZ Limited

INN (International Name):

Salmeterol xinafoate 36.3 µg (Equiv. to 25 µg Salmeterol base per acuation)

Dosage:

25 mcg/dose

Pharmaceutical form:

Aerosol inhaler, metered dose

Composition:

Active: Salmeterol xinafoate 36.3ug equivalent to to 25 µg Salmeterol base per acuation   Excipient: Dichlorodifluoromethane Lecithin Trichlorofluoromethane

Units in package:

Inhaler, metered, 120 dose, Sample pack, 1 U

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Glaxo Wellcome Manufacturing Pte Ltd

Product summary:

Package - Contents - Shelf Life: Inhaler, metered, - 60 dose units - 24 months from date of manufacture stored at or below 30°C - Inhaler, metered, Sample pack - 120 dose units - 24 months from date of manufacture stored at or below 30°C - Inhaler, metered, - 120 dose units - 24 months from date of manufacture stored at or below 30°C

Authorization date:

1992-03-26